HL-074167/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	2
2006	2
2007	1
2008	2
2009	3
2011	1
2014	1
2024	0

1

Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.

Imig JD. Imig JD. Cardiovasc Drug Rev. 2006 Summer;24(2):169-88. doi: 10.1111/j.1527-3466.2006.00169.x. Cardiovasc Drug Rev. 2006. PMID: 16961727 Review.

2

P2 receptors in renal autoregulation.

Guan Z, Fellner RC, Van Beusecum J, Inscho EW. Guan Z, et al. Curr Vasc Pharmacol. 2014;12(6):818-28. doi: 10.2174/15701611113116660152. Curr Vasc Pharmacol. 2014. PMID: 24066935 Free PMC article. Review.

3

Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.

Imig JD. Imig JD. Am J Physiol Renal Physiol. 2005 Sep;289(3):F496-503. doi: 10.1152/ajprenal.00350.2004. Am J Physiol Renal Physiol. 2005. PMID: 16093425 Free article. Review.

4

Eicosanoids and renal vascular function in diseases.

Imig JD. Imig JD. Clin Sci (Lond). 2006 Jul;111(1):21-34. doi: 10.1042/CS20050251. Clin Sci (Lond). 2006. PMID: 16764555 Review.

5

P2 receptor regulation of [Ca2+]i in cultured mouse mesangial cells.

Rivera I, Zhang S, Fuller BS, Edwards B, Seki T, Wang MH, Marrero MB, Inscho EW. Rivera I, et al. Am J Physiol Renal Physiol. 2007 May;292(5):F1380-9. doi: 10.1152/ajprenal.00349.2006. Epub 2007 Jan 9. Am J Physiol Renal Physiol. 2007. PMID: 17213463 Free article.

6

Purinoceptor regulation of renal tubular transport is coming of age.

Inscho EW. Inscho EW. Am J Physiol Renal Physiol. 2009 Nov;297(5):F1166-7. doi: 10.1152/ajprenal.00506.2009. Epub 2009 Sep 9. Am J Physiol Renal Physiol. 2009. PMID: 19741013 Free PMC article. No abstract available.

7

P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet.

Inscho EW, Cook AK, Clarke A, Zhang S, Guan Z. Inscho EW, et al. Hypertension. 2011 Apr;57(4):780-7. doi: 10.1161/HYPERTENSIONAHA.110.168955. Epub 2011 Feb 14. Hypertension. 2011. PMID: 21321307 Free PMC article.

8

Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.

Manhiani M, Quigley JE, Knight SF, Tasoobshirazi S, Moore T, Brands MW, Hammock BD, Imig JD. Manhiani M, et al. Am J Physiol Renal Physiol. 2009 Sep;297(3):F740-8. doi: 10.1152/ajprenal.00098.2009. Epub 2009 Jun 24. Am J Physiol Renal Physiol. 2009. PMID: 19553349 Free PMC article.

9

Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.

Imig JD, Dimitropoulou C, Reddy DS, White RE, Falck JR. Imig JD, et al. Microcirculation. 2008 Feb;15(2):137-50. doi: 10.1080/10739680701456960. Microcirculation. 2008. PMID: 18260004 Free PMC article.

10

An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.

Dorrance AM, Rupp N, Pollock DM, Newman JW, Hammock BD, Imig JD. Dorrance AM, et al. J Cardiovasc Pharmacol. 2005 Dec;46(6):842-8. doi: 10.1097/01.fjc.0000189600.74157.6d. J Cardiovasc Pharmacol. 2005. PMID: 16306811 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year